|
16 February, 2017
|
ICON Reports Fourth Quarter and Full Year 2016 Results
|
|
|
09 January, 2017
|
ICON Issues Financial Guidance for Full Year 2017
|
|
|
27 October, 2016
|
ICON Further Enhances Clinical Trial Feasibility, Protocol Optimisation and Patient Recruitment Capabilities with TriNetX
|
|
|
24 October, 2016
|
ICON Announces Appointment of Mr. Ronan Murphy to Board of Directors
|
|
|
20 October, 2016
|
ICON Announces Executive Leadership Transition
|
|
|
20 October, 2016
|
ICON Reports Third Quarter 2016 Results
|
|
|
19 September, 2016
|
ICON Completes the Acquisition of Clinical Research Management, Inc.
|
|
|
26 July, 2016
|
ICON Reports Second Quarter 2016 Results
|
|
|
25 July, 2016
|
ICON Shareholders Vote in Favour of All Resolutions at its Annual General Meeting
|
|
|
30 June, 2016
|
ICON to Acquire Clinical Research Management, Inc.
|
|
|
23 June, 2016
|
ICON: DIA Live to Provide a Digital Window into DIA Conference 2016
|
|
|
15 June, 2016
|
New Research from ICON Demonstrates Support for ‘Bring Your Own Device' Approach in Clinical Trials
|
|
|
10 June, 2016
|
ICON Announces Service Agreement with Pfizer
|
|
|
16 May, 2016
|
ICON and Pfizer Honoured as Clinical Research Team of the Year at the Clinical and Research Excellence Awards
|
|
|
26 April, 2016
|
ICON Reports First Quarter 2016 Results
|
|
|
29 March, 2016
|
Mr. Thomas Lynch Notifies ICON of His Retirement as Chairman and That He Will Not Stand for Re-Election to the Board of Directors at the Annual General Meeting
|
|
|
08 March, 2016
|
ICON Selected by the International Consortium for Health Outcomes Measurement to Help Advance Value-based Healthcare
|
|
|
23 February, 2016
|
ICON Reports Fourth Quarter and Full Year 2015 Results and Issues 2016 Earnings Guidance
|
|
|
09 February, 2016
|
ICON selected by Genomics England to support the largest genome sequencing project of its kind for cancer and rare diseases
|
|
|
05 January, 2016
|
ICON Secures Investment Grade Credit Ratings
|
|
